AbCellera taps capital markets for $200m to bankroll menopause antibody
CompaniesAbCellera BiologicsAssetsABCL635Diseasesmenopause
Signals
Every pharma-relevant, de-duplicated event surfaced so far, primary source first. Client-scoped signals are never shown here.
Where AI creates value in modern market access
PTC Therapeutics wins $211m Sangamo auction for rare gene therapy
CompaniesSangamo TherapeuticsPTC TherapeuticsEli LillyAssetsisaralgagene civaparvoveczinc finger platformcapsid delivery platformmolecular integrase platformprion disease programDiseasesFabry diseaseprion disease
Boulevard emerges from stealth with $65m to reimagine autoimmune treatment
CompaniesBoulevardDeerfield ManagementAssetsBLVD101BLVD201BLVD301Diseaseskidney diseasesystemic lupus erythematosusSjögren's disease
How FDA discussions evolve in rare disease program
CompaniesPolaryx TherapeuticsDiseasesrare, pediatric lysosomal storage disorders
The long game: How Boehringer Ingelheim’s private ownership fuels bold, early-stage partnerships
CompaniesBoehringer Ingelheim
Fresenius opens €200m gateway fund for emerging biotech talent
CompaniesFresenius
New schema resolves subject ID challenges in CRO sector, researchers say
mAb combo therapy misses the mark in Phase III clinical trial for advanced colorectal cancer
CompaniesBristol Myers SquibbMirati TherapeuticsAssetscetuximabadagrasibDiseasesadvanced colorectal cancer
Partnership-first approach: Inside Servier's Asia innovation strategy
CompaniesServierBioNovaInsilico Medicine
Eyes on Asia: Tanabe Pharma, KYAN Technologies, Biogen
CompaniesAxiomPathos AISamsung Biologics
Getting siRNAs into the brain without transferrin receptors
CompaniesManifold BioAssetsantibodiesoligosDiseasesamyotrophic lateral sclerosis (ALS)Alzheimer's
Xencor’s Celia Eckert explains why psychological safety is the foundation of a compliant culture
CompaniesXencor
SK pharmteco Marks Construction Progress with Ribbon Cutting for Two Advanced Manufacturing Facilities at Swords, Ireland Campus
CompaniesSK pharmteco
Applied Biologics Announces Acceptance of XWRAP® Translational Research for Presentation at SAWC Fall 2026
CompaniesApplied BiologicsAssetsXWRAP
Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event
CompaniesCo-Diagnostics
Kenai Therapeutics Appoints Mark Gergen to Board of Directors
CompaniesKenai Therapeutics
GE HealthCare appoints William Grogan as Chief Financial Officer
CompaniesGE HealthCare
Cytovance Biologics Launches Standalone Analytical Services to Accelerate Biologics Development
CompaniesCytovance Biologics
Aqua Medical Treats First West Coast Patient in FDA-Approved IDE Trial of Investigational PIMA Procedure for Type 2 Diabetes
CompaniesAqua MedicalAssetsPIMA procedureradiofrequency vapor ablation (RFVA) platformDiseasestype 2 diabetes